Trends in Drug Pricing and Reimbursement: Thought Leaders in Health Law Video Series

May 2017

Click above or watch via YouTube, Vimeo, MP4, or WMV.

In this Thought Leaders in Health Law® video, John S. Linehan, Alan J. Arville, and Constance A. Wilkinson, attorneys in the Health Care and Life Sciences practice, discuss payment model changes, new regulatory approaches, and enforcement issues related to drug pricing and reimbursements.

This video examines the following:

  • Innovation in the pharmaceutical industry that is influencing cost
  • New outcomes-based pricing and government reimbursement models 
  • The use of government enforcement and scrutiny as a tool to manage cost
  • The difficulty of creating robust drug pricing reform in the future

Epstein Becker Green works across multiple legal and regulatory fields to serve pharmaceutical companies. Learn more about the solutions and services that we provide.

The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.

Trouble viewing the video? Please contact Kelli Sakalousky at [email protected] and mention whether you were at home or working within a corporate network. We'd also love your suggestions for future topics. Subscribe to our Health Care and Life Sciences email list to be notified of future video releases.

THOUGHT LEADERS IN HEALTH LAW® is a registered trademark of Epstein Becker & Green, P.C.